SCHEMBL61005

SCHEMBL61005

CC(C)[C@@H](N)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL545348 1.00
SCHEMBL289124 1.00
Hydrochloric Acid SCHEMBL15390233 0.97 GABRP (0.42)
Hydrochloric Acid SCHEMBL15268775 0.97 GABRP (0.42)
Hydrochloric Acid SCHEMBL5194767 0.97 GABRP (0.42)
Acetic Acid SCHEMBL2859784 0.95 TDP1 (0.42)
Acetic Acid SCHEMBL6685363 0.95 TDP1 (0.42)
SCHEMBL3998190 0.84 GABRP (0.41)
SCHEMBL3993722 0.84 GABRP (0.41)
SCHEMBL3995021 0.84 GABRP (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 427 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326884-A1 COMPOSITIONS COMPRISING AMINO ACID ADDUCTS AND HYDROXY SILANES, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME TRUCAPSOL LLC (US) 2025-10-23 US claimed
CN-118125936-A N-acyl ethanolamide derivative, preparation method and application thereof 南京清普生物科技有限公司 2024-06-04 CN claimed
EP-4251638-A1 PEPTIDES AND USES THEREOF IN MODULATION OF AMYLOID-BETA PROTEIN DEGRADING PROTEASES UNIVERSITY OF QUEENSLAND (AU) 2023-10-04 EP claimed
WO-2023044455-A2 RNA STABILIZATION TEAM MEDICAL LLC (US) 2023-03-23 WO claimed
WO-2022109679-A1 PEPTIDES AND USES THEREOF IN MODULATION OF AMYLOID-BETA PROTEIN DEGRADING PROTEASES UNIVERSITY OF QUEENSLAND (AU) 2022-06-02 WO claimed
US-20150011730-A1 Cyclin Based Inhibitors of CDK2 and CDK4 NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-01-08 US claimed
US-20140296484-A1 Cyclin Based Inhibitors of CDK2 and CDK4 UNIVERSITY OF SOUTH CAROLINA (US) 2014-10-02 US claimed
US-8679316-B2 Aqueous, acid bath and method for the electrolytic deposition of copper ATOTECH DEUTSCHLAND GMBH (DE) 2014-03-25 US claimed
US-8608922-B2 Biosensor for continuous monitoring of metabolites and proteins and methods of manufacture thereof THE UNIVERSITY OF CONNECTICUT (US) 2013-12-17 US claimed
EP-2366786-A2 Cytokine receptor modulators and uses thereof VALORISATION HSJ, Société en Commandite (CA) 2011-09-21 EP claimed
WO-2009132861-A2 AQUEOUS, ACID BATH AND METHOD FOR THE ELECTROLYTIC DEPOSITION OF COPPER ATOTECH DEUTSCHLAND GMBH (DE) 2009-11-05 WO claimed
EP-1885855-A4 CYTOKINE RECEPTOR MODULATORS AND USES THEREOF VALORISATION HSJ SOC EN COMMAN (CA) 2009-03-04 EP claimed
US-20090048161-A1 Cytokine receptor modulators and uses thereof VALORISATION HSJ, SOCIETE EN COMMANDITE (CA) 2009-02-19 US claimed
WO-2009007849-A2 IL-23 RECEPTOR ANTAGONISTS AND USES THEREOF VALORISATION HSJ, SOCIETE EN COMMANDITE (CA) 2009-01-15 WO claimed
EP-1751175-A4 INTERLEUKIN-1 RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS OF TREATMENT VALORISATION RECH SOC EN COMMA (CA) 2008-12-17 EP claimed
EP-1885855-A2 CYTOKINE RECEPTOR MODULATORS AND USES THEREOF VALORISATION HSJ, Société en Commandite (CA) 2008-02-13 EP claimed
EP-1751175-A1 INTERLEUKIN-1 RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS OF TREATMENT Valorisation-Recherche, Société en Commandite (CA) 2007-02-14 EP claimed
WO-2007004060-A2 CYTOKINE RECEPTOR MODULATORS AND USES THEREOF VALORISATION HSJ, SOCIETE EN COMMANDITE (CA) 2007-01-11 WO claimed
US-20060094663-A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment VALORISATION-RECHERCHE, SOCIETE EN COMMANDITE (CA) 2006-05-04 US claimed
WO-2005105830-A1 INTERLEUKIN-1 RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS OF TREATMENT VALORISATION-RECHERCHE, SOCIETE EN COMMANDITE (CA) 2005-11-10 WO claimed